European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.
Articles
Neoadjuvant chemotherapy in the management of cervical cancer. A long and winding road. State of the art
Neoadjuvant chemotherapy in the management of cervical cancer. A long and winding road. State of the art
DOI: 10.22514/ejgo.2024.111
Evaluating the synergistic impact of PD-1/PD-L1 blockade and platinum-based chemotherapy in modulating the tumor microenvironment for enhanced T cell-mediated immune responses in advanced endometrial cancer: a meta-analysis
Evaluating the synergistic impact of PD-1/PD-L1 blockade and platinum-based chemotherapy in modulating the tumor microenvironment for enhanced T cell-mediated immune responses in advanced endometrial cancer: a meta-analysis
DOI: 10.22514/ejgo.2024.112
Nomogram for the prediction of disease-free survival in FIGO 2023 stage IA2 endometrial cancer patients
Nomogram for the prediction of disease-free survival in FIGO 2023 stage IA2 endometrial cancer patients
DOI: 10.22514/ejgo.2024.087
Trabectedin-pegylated liposomal doxorubicin compared to cisplatin desensitization regimen-paclitaxel in ovarian cancer patients
Trabectedin-pegylated liposomal doxorubicin compared to cisplatin desensitization regimen-paclitaxel in ovarian cancer patients
DOI: 10.22514/ejgo.2024.114
Anticancer potential of Marsdenia tenacissima extract: modulation of proliferation, apoptosis and SBEM gene expression in triple-negative breast cancer MDA-MB-231 cells
Anticancer potential of Marsdenia tenacissima extract: modulation of proliferation, apoptosis and SBEM gene expression in triple-negative breast cancer MDA-MB-231 cells
DOI: 10.22514/ejgo.2024.115
Necroptosis-related gene to construct a signature to predict the prognosis and immune features in patients with cervical cancer
Necroptosis-related gene to construct a signature to predict the prognosis and immune features in patients with cervical cancer
DOI: 10.22514/ejgo.2024.116
Management of persistent post-treatment cervical FDG-avidity after definitive chemoradiation for locally advanced cervical cancer
Management of persistent post-treatment cervical FDG-avidity after definitive chemoradiation for locally advanced cervical cancer
DOI: 10.22514/ejgo.2024.117
Global knowledge map of sentinel lymph node fluorescence mapping in endometrial carcinoma: a visual analysis
Global knowledge map of sentinel lymph node fluorescence mapping in endometrial carcinoma: a visual analysis
DOI: 10.22514/ejgo.2024.118
Development and pilot evaluation of a decision aid for modern cervical screening
Development and pilot evaluation of a decision aid for modern cervical screening
DOI: 10.22514/ejgo.2024.119
The effect of postoperative chemotherapy on serum lipids and prognosis in patients with advanced ovarian cancer
The effect of postoperative chemotherapy on serum lipids and prognosis in patients with advanced ovarian cancer
DOI: 10.22514/ejgo.2024.120
Introduction of peri-operative care bundle in vulval cancer in a UK regional cancer center
Introduction of peri-operative care bundle in vulval cancer in a UK regional cancer center
DOI: 10.22514/ejgo.2024.122
Polyphyllin VII inhibits the growth of HPV-positive cervical cancer cells via the PI3K/Akt pathway
Polyphyllin VII inhibits the growth of HPV-positive cervical cancer cells via the PI3K/Akt pathway
DOI: 10.22514/ejgo.2024.123
Meis1 restrains the growth and epithelial-mesenchymal transition of breast cancer cells through the HOXB13/PI3K/AKT signaling pathway
Meis1 restrains the growth and epithelial-mesenchymal transition of breast cancer cells through the HOXB13/PI3K/AKT signaling pathway
DOI: 10.22514/ejgo.2024.124
Research on the application of 4C continued nursing model in postoperative care of breast cancer patients
Research on the application of 4C continued nursing model in postoperative care of breast cancer patients
DOI: 10.22514/ejgo.2024.126
CPNE1 as prognostic marker and regulator of cell growth and glycolysis in endometrial cancer
CPNE1 as prognostic marker and regulator of cell growth and glycolysis in endometrial cancer
DOI: 10.22514/ejgo.2024.127
Ki67 can be used as a predictive factor for the effectiveness of neoadjuvant chemotherapy in breast cancer patients
Ki67 can be used as a predictive factor for the effectiveness of neoadjuvant chemotherapy in breast cancer patients
DOI: 10.22514/ejgo.2024.128
KIF2C promotes doxorubicin resistance in ovarian cancer cells and increases cancer cell glycolysis by upregulating PKM2
KIF2C promotes doxorubicin resistance in ovarian cancer cells and increases cancer cell glycolysis by upregulating PKM2
DOI: 10.22514/ejgo.2024.129
FOXK2 affects the motility of endometrial cancer cells by mediating ZEB1
FOXK2 affects the motility of endometrial cancer cells by mediating ZEB1
DOI: 10.22514/ejgo.2024.130
The importance of Delta prognostic nutrition index as an early success indicator of optimal cytoreductive surgery in epithelial ovarian cancer patients
The importance of Delta prognostic nutrition index as an early success indicator of optimal cytoreductive surgery in epithelial ovarian cancer patients
DOI: 10.22514/ejgo.2024.131
Longitudinal study on symptom clusters of patients undergoing breast reconstruction surgery after breast cancer
Longitudinal study on symptom clusters of patients undergoing breast reconstruction surgery after breast cancer
DOI: 10.22514/ejgo.2024.132
Sauchinone inhibits the growth and epithelial-mesenchymal transition of ovarian cancer cells
Sauchinone inhibits the growth and epithelial-mesenchymal transition of ovarian cancer cells
DOI: 10.22514/ejgo.2024.133
An unusual occurrence of ovarian fibroma originating from an autoamputated ovary: a case report
An unusual occurrence of ovarian fibroma originating from an autoamputated ovary: a case report
DOI: 10.22514/ejgo.2024.134
Published Ahead of Print
Expression and clinical significance of CSAD in type I endometrial carcinoma
Expression and clinical significance of CSAD in type I endometrial carcinoma
Online publish date: 28 October 2024
DOI: 10.22514/ejgo.2024.110
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Online publish date: 15 September 2023
DOI: 10.22514/ejgo.2023.072
Prognostic value of Ki-67 in patients with ovarian cancer
Prognostic value of Ki-67 in patients with ovarian cancer
Online publish date: 24 July 2023
DOI: 10.22514/ejgo.2023.051
Special Issues
Quality of Life in Gynecologic Malignancies
Keywords: Quality of life; Palliative care; Symptom management
Editor: Lori Spoozak, MD
Submission deadline: 31 December 2024
Endometrial Cancer and Fertility Preservation in the Denatality ERA
Keywords: Endoemtrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve
Editor: Dr. Giuseppe Gullo, MD, PhD,Dr. Alessandra Lopez, MD,Dr. Valentina Billone, MD, PhD St.
Submission deadline: 31 December 2025
Advances in Ovarian Cancer Research
Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation
Editor: Basel Refky, MD
Submission deadline: 31 July 2025
Current Update in the Treatment of Cervical Cancer
Keywords: Radical hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2024
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD,David Mysona, MD
Submission deadline: 30 March 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.